BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1072 related articles for article (PubMed ID: 21044653)

  • 1. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
    Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset.
    Tsai SJ; Hong CJ; Liu HC; Liu TY; Hsu LE; Lin CH
    Neuropsychobiology; 2004; 49(1):10-2. PubMed ID: 14730194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
    Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Neuropsychobiology; 2007; 55(3-4):151-5. PubMed ID: 17657167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory study.
    Zdanys KF; Kleiman TG; Zhang H; Ozbay F; MacAvoy MG; Gelernter J; van Dyck CH
    J Alzheimers Dis; 2009; 17(4):887-98. PubMed ID: 19542613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction.
    Decoster J; van Os J; Kenis G; Henquet C; Peuskens J; De Hert M; van Winkel R
    Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):363-9. PubMed ID: 21305693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
    Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
    Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF genetic variations increase the risk of Alzheimer's disease-related depression.
    Borroni B; Grassi M; Archetti S; Costanzi C; Bianchi M; Caimi L; Caltagirone C; Di Luca M; Padovani A
    J Alzheimers Dis; 2009; 18(4):867-75. PubMed ID: 19661618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
    Suchanek R; Owczarek A; Paul-Samojedny M; Kowalczyk M; Kucia K; Kowalski J
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):88-94. PubMed ID: 23487199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
    J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.
    Chuu JY; Taylor JL; Tinklenberg J; Noda A; Yesavage J; Murphy GM
    J Alzheimers Dis; 2006 Mar; 9(1):43-9. PubMed ID: 16627933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
    Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
    Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF Val66Met variants and brain volume changes in non-affective psychosis patients and healthy controls: a 3 year follow-up study.
    Suárez-Pinilla P; Roiz-Santiáñez R; de la Foz VO; Mata I; Fañanas L; Brambilla P; Ruíz-Pérez E; Crespo-Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():201-6. PubMed ID: 23748016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
    Nagata T; Shinagawa S; Nukariya K; Yamada H; Nakayama K
    Dement Geriatr Cogn Disord; 2012; 33(4):266-72. PubMed ID: 22699449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.